The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Axonal damage correlates with disability in patients with relapsing- remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
Open accessAbstract
It has been difficult to establish a strong correlation between total brain T2-weighted lesion volume on MRI and clinical disability in multiple sclerosis, in part because of the lack of pathological specificity of T2-weighted MRI signal changes. Proton magnetic resonance spectroscopy studies have shown that measurements of the resonance intensity of N-acetylaspartate (which is localized exclusively in neurons and neuronal processes in the mature brain) can provide a specific index of axonal damage or dysfunction. Here we report a 30-month longitudinal study of 29 patients with multiple sclerosis who had either a relapsing or a secondary progressive clinical course. Conventional brain MRI and single-voxel proton magnetic resonance spectroscopy examinations were obtained at intervals of 6-8 months with concurrent clinical evaluation. At the onset of the study, the brain N-acetylaspartate:creatine resonance intensity ratio was abnormally low for the whole group of patients (control mean = 2.93 +/- 0.2, patient mean = 2.56 +/- 0.4, P < 0.005). There were no significant differences between the relapsing and secondary progressive subgroups. Over the follow-up period, there was a trend towards a decrease (8%) in the brain N-acetylaspartate:creatine ratio for the 11 relapsing patients and a significant (P < 0.001) correlation between changes in the brain N-acetylaspartate:creatine ratio and expanded disability scale scores for the patients in this group. This correlation was even more evident for the patients who had clinically relevant relapses during the 30 months of follow-up (seven of 11 patients). Increases in T2-weighted lesion volumes (35% in 30 months for the group as a whole, P < 0.0001, without differences between the subgroups) did not correlate with disability either in the group of patients as a whole or in the different subgroups. We conclude that indices of axonal damage or loss such as brain N-acetylaspartate may provide a specific measure of pathological changes relevant to disability. Total T2-weighted lesion volumes, although more sensitive to changes with time than brain N-acetylaspartate, may be less relevant to understanding the progression of disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Unbalanced Repeated-Measures Models with Structured Covariance Matrices
Jennrich, R. I., & Schluchter, M. D. (1986) · Biometrics · doi:10.2307/2530695 · Cited by 1,325
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 643
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
Simmons, M. L., Frondoza, C. G., & Coyle, J. T. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90101-s · Cited by 626
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.1.49 · Cited by 534
Urenjak, J., Williams, S. R., Gadian, D. G., & Noble, M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08875.x · Cited by 503
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444
Anatomical mapping of functional activation in stereotactic coordinate space
Evans, A. C., Marrett, S., Neelin, P., Collins, L., Worsley, K., Dai, W., Milot, S., Meyer, E., & Bub, D. (1992) · NeuroImage · doi:10.1016/1053-8119(92)90006-9 · Cited by 426
Correlation of magnetization transfer ration with clinical disability in multiple sclerosis
Gass, A., Barker, G. J., Kidd, D., Thorpe, J. W., MacManus, D., Brennan, A., Tofts, P. S., Thompson, A. J., McDonald, W. I., & Miller, D. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360113 · Cited by 343
Immunohistochemical localization of N-acetylaspartate in rat brain
Moffett, J. R., Aryan Namboodiri, M. A., Cangro, C. B., & Neale, J. H. (1991) · NeuroReport · doi:10.1097/00001756-199103000-00005 · Cited by 334
Arnold, D. L., Matthews, P. M., Francis, G., O'Connor, J., & Antel, J. P. (1992) · Annals of Neurology · doi:10.1002/ana.410310302 · Cited by 314
Chemical pathology of acute demyelinating lesions and its correlation with disability
De Stefano, N., Matthews, P. M., Antel, J. P., Preul, M., Francis, G., & Arnold, D. L. (1995) · Annals of Neurology · doi:10.1002/ana.410380610 · Cited by 304
Self-citationFilippi, M., Paty, D. W., Kappos, L., Barkhof, F., Compston, D. A. S., Thompson, A. J., Zhao, G. J., Wiles, C. M., McDonald, W. I., & Miller, D. H. (1995) · Neurology · doi:10.1212/wnl.45.2.255 · Cited by 296
van Walderveen, M. A. A., Barkhof, F., Hommes, O. R., Polman, C. H., Tobi, H., Frequin, S. T. F. M., & Valk, J. (1995) · Neurology · doi:10.1212/wnl.45.9.1684 · Cited by 294
The longstanding MS lesion. A quantitative MRI and electron microscopic study
BARNES, D., MUNRO, P. M. G., YOUL, B. D., PRINEAS, J. W., & MCDONALD, W. I. (1991) · Brain · doi:10.1093/brain/114.3.1271 · Cited by 256
Willoughby, E. W., Grochowski, E., Li, D. K. B., Oger, J., Kastrukoff, L. F., & Paty, D. W. (1989) · Annals of Neurology · doi:10.1002/ana.410250107 · Cited by 254
Smith, M. E., Stone, L. A., Albert, P. S., Frank, J. A., Martin, R., Armstrong, M., Maloni, H., McFarlin, D. E., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410330511 · Cited by 241
Husted, C. A., Goodin, D. S., Hugg, J. W., Maudsley, A. A., Tsuruda, J. S., de Bie, S. H., Fein, G., Matson, G. B., & Weiner, M. W. (1994) · Annals of Neurology · doi:10.1002/ana.410360207 · Cited by 219
Matthews, P. M., Francis, G., Antel, J., & Arnold, D. L. (1991) · Neurology · doi:10.1212/wnl.41.8.1251 · Cited by 202
Arnold, D. L., Riess, G. T., Matthews, P. M., Francis, G. S., Collins, D. L., Wolfson, C., & Antel, J. P. (1994) · Annals of Neurology · doi:10.1002/ana.410360115 · Cited by 192
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Grossman, R. I., Braffman, B. H., Brorson, J. R., Goldberg, H. I., Silberberg, D. H., & Gonzalez-Scarano, F. (1988) · Radiology · doi:10.1148/radiology.169.1.3420246 · Cited by 180
Matthews, P. M., Pioro, E., Narayanan, S., Stefano, N. D., Fu, L., Francis, G., Antel, J., Wolfson, C., & Arnold, D. L. (1996) · Brain · doi:10.1093/brain/119.3.715 · Cited by 165
Proton magnetic resonance spectroscopy in multiple sclerosis
Wolinsky, J. S., Narayana, P. A., & Fenstermacher, M. J. (1990) · Neurology · doi:10.1212/wnl.40.11.1764 · Cited by 145
Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis
Sajja, B. R., Wolinsky, J. S., & Narayana, P. A. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2008.08.002 · Cited by 138
Longitudinal MRI in multiple sclerosis
Khoury, S. J., Guttmann, C. R. G., Orav, E. J., Hohol, M. J., Ahn, S. S., Hsu, L., Kikinis, R., Mackin, G. A., Jolesz, F. A., & Weiner, H. L. (1994) · Neurology · doi:10.1212/wnl.44.11.2120 · Cited by 134
Axonal dystrophy as a consequence of long-term demyelination.
Raine, C. S., & Cross, A. H. (1989) · PubMed · Cited by 131
Stone, L. A., Smith, M. E., Albert, P. S., Bash, C. N., Maloni, H. W., Frank, J. A., & McFarland, H. F. (1995) · Neurology · doi:10.1212/wnl.45.6.1122 · Cited by 130
High Resolution Proton NMR Spectroscopy of Multiple Sclerosis Lesions
Davies, S., Newcombe, J., Williams, S. R., McDonald, W. I., & Clark, J. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020742.x · Cited by 104
Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis
Miller, D. H., Austin, S. J., Connelly, A., Youl, B. D., Gadian, D. G., & McDonald, W. I. (1991) · The Lancet · doi:10.1016/0140-6736(91)93383-k · Cited by 103
de Beer, R., van den Boogaart, A., ORMONDT, D. V., et al. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050403 · Cited by 101
Magnetic resonance in monitoring the treatment of multiple sclerosis
Miller, D. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360720 · Cited by 94
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
Paty, D. W., Li, D. K. B., Oger, J. J.-F., Kastrukoff, L. F., Koopmans, R. A., Tanton, E., & Zhao, G. J. (1994) · Annals of Neurology · doi:10.1002/ana.410360721 · Cited by 90
The Pathological and Clinical Dynamics of Multiple Sclerosis
McDonald, W. I. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199407000-00003 · Cited by 90
Stefano, N. D., Matthews, P. M., Narayanan, S., Francis, G., Antel, J. P., & Arnold, D. L. (1997) · Neurology · doi:10.1212/wnl.49.4.1138 · Cited by 77
Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T
Pan, J. W., Hetherington, H. P., Vaughan, J. T., Mitchell, G. W., Pohost, G. M., & Whitaker, J. N. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910360113 · Cited by 73
Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study
Filippi, M., Barker, G. J., Horsfield, M. A., Sacares, P., MacManus, D. G., Thompson, A. J., Tofts, P. S., McDonald, W. I., & Miller, D. H. (1994) · Journal of Neurology · doi:10.1007/bf00863776 · Cited by 48
MRI and Proton MRS in the Evaluation of Multiple Sclerosis
Arnold, D. L., Matthews, P. M., & Stefano, N. D. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5863-7_11 · Cited by 10
Cited by
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
Metadata
- Authors
- De Stefano, N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-08-01
- Volume
- 121
- Issue
- 8
- Pages
- 1469-1477
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1933220919
- Cited by
- 492
- References
- 43
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.